Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
VISEN PharmaceuticalsHKSE:02561 7 Days Inventory is 317.90 as of Jun. 2026, which is 92% below its 10-year median of 3,826.83. GuruFocus rates HKSE:02561 with a GF Score™ of 7/100. The stock has 5 warning signs investors should review. Among 918 Drug Manufacturers companies, VISEN Pharmaceuticals ranks worse than 99.56% on this metric.
The historical rank and industry rank for VISEN Pharmaceuticals's Days Inventory or its related term are showing as below:
HKSE:02561'
s Days Inventory Range Over the Past 10 Years
Min: 635.8 Med: 3826.83 Max: 3826.83
Current: 635.8
During the past 4 years, VISEN Pharmaceuticals's highest Days Inventory was 3826.83. The lowest was 635.80. And the median was 3826.83.
HKSE:02561's Days Inventory is ranked worse than 99.56% of 918
companies
in the Drug Manufacturers industry
Industry Median: 164.705
vs HKSE:02561: 635.80
If a company builds up inventory, it may mean it is having difficulties selling its goods.
Inventory Turnover measures how fast the company turns over its inventory within a year.
VISEN Pharmaceuticals's Inventory Turnover for the
six
months ended in Jun. 2026 was 0.57.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
VISEN Pharmaceuticals's Inventory-to-Revenue for the
six
months ended in Jun. 2026 was 0.83.
VISEN Pharmaceuticals (HKSE:02561) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
VISEN Pharmaceuticals's Inventory Turnover for the
six
months ended in Jun. 2026 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
VISEN Pharmaceuticals's Inventory to Revenue for the
six
months ended in Jun. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
VISEN Pharmaceuticals Days Inventory Related Terms
VISEN Pharmaceuticals Days Inventory Historical Data
* Premium members only.
The historical data trend for VISEN Pharmaceuticals's Days Inventory can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, VISEN Pharmaceuticals's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
VISEN Pharmaceuticals Days Inventory vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, VISEN Pharmaceuticals's Days Inventory distribution charts can be found below:
* The bar in red indicates where VISEN Pharmaceuticals's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
VISEN Pharmaceuticals (HKSE:02561) has a Days Inventory of 317.90 as of Jun. 2026. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on VISEN Pharmaceuticals and its competitors. This is 92% below median its historical median of 3,826.83. Over the past decade, VISEN Pharmaceuticals' Days Inventory has ranged from 635.80 to 3,826.83. According to the industry distribution chart, VISEN Pharmaceuticals ranks #914 out of 918 companies in the Drug Manufacturers industry, placing it in the top 99.6%.
Is VISEN Pharmaceuticals' Days Inventory too high?
VISEN Pharmaceuticals' current Days Inventory of 317.90 is 92% below median its 10-year median of 3,826.83. Over the past 10 years, this metric has ranged from a low of 635.80 to a high of 3,826.83. The Drug Manufacturers industry median Days Inventory is 164.71. VISEN Pharmaceuticals' value of 317.90 is 93% above this industry median. Based on the distribution chart, VISEN Pharmaceuticals ranks #914 out of 918 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers. Overall, VISEN Pharmaceuticals has a GF Score™ of 7/100, reflecting its overall financial health beyond just this single metric.
How does VISEN Pharmaceuticals' Days Inventory compare to ZTS?
According to the Drug Manufacturers industry distribution chart, VISEN Pharmaceuticals ranks #914 out of 918 companies for Days Inventory. This places VISEN Pharmaceuticals in the lower half of its industry. The industry median Days Inventory is 164.71. VISEN Pharmaceuticals' value of 317.90 is 93% above this benchmark. Historically, VISEN Pharmaceuticals' own Days Inventory has ranged from 635.80 to 3,826.83 over the past decade. While the company's 10-year median is 3,826.83 vs. the industry median of 164.71, VISEN Pharmaceuticals has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Drug Manufacturers company?
The median Days Inventory among Drug Manufacturers companies is 164.71, based on 918 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. VISEN Pharmaceuticals's current Days Inventory of 317.90 is 93% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on VISEN Pharmaceuticals and its competitors. For the Drug Manufacturers industry, the median Days Inventory is 164.71 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. VISEN Pharmaceuticals's current Days Inventory is 317.90, which is 92% below median its own 10-year median of 3,826.83. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is VISEN Pharmaceuticals stock overvalued right now?
VISEN Pharmaceuticals (HKSE:02561) has a current Days Inventory of 317.90. The current Days Inventory is 317.90, which is 92% below median its 10-year median of 3,826.83 and 93% above the Drug Manufacturers industry median of 164.71. VISEN Pharmaceuticals' overall GF Score™ is 7/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For VISEN Pharmaceuticals (HKSE:02561), the current Days Inventory is 317.90 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
VISEN Pharmaceuticals is a late-stage, near-commercialization biopharmaceutical company focused on providing treatments in selected endocrinology diseases in China. It has one Core Product and two other pipeline drug candidates. Its Core Product, lonapegsomatropin, is a once-weekly long-acting growth hormone replacement therapy for the treatment of pediatric growth hormone deficiency (PGHD), a common short stature in patients aged under 18 caused by insufficient growth hormone. TransCon CNP (navepegritide), one of its key drug candidates, is a long-acting prodrug of c-type natriuretic peptide for the treatment of achondroplasia (ACH), a short-limbed dwarfism that results in severe skeletal complications and comorbidities.
7GF Score
Get the complete analysis for HKSE:02561
Days Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HKSE:02561 has been successfully added to your 
